Search clinical trials for: Placebo of AD-224C

Total 28199 results

Addpharma Inc.

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of AD-224

Hypertension,Essential
Addpharma Inc.

Recruiting

A Study to Evaluate the Efficacy and Safety of AD-223

Hypertension,Essential

Korea, Republic of
Addpharma Inc.

Completed

A Study to Evaluate the Efficacy and Safety of AD-208

Androgenetic Alopecia

Korea, Republic of
Zhejiang Hisun Pharmaceutical Co. Ltd.

Unknown

Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease (WAY)

Alzheimer's Disease

China
Addpharma Inc.

Completed

A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A

Primary Hypercholesterolemia

Korea, Republic of
Addpharma Inc.

Recruiting

Phase III Study to Evaluate the Efficacy and Safety of AD-209

Hypertension,Essential

Korea, Republic of
Addpharma Inc.

Completed

A Study to Evaluate the Efficacy and Safety of AD-209

Hypertension, Essential

Korea, Republic of
Abbott Nutrition

Completed

Evaluation of AN777 in Elderly Subjects

Aged

United States
Samus Therapeutics, Inc.

Terminated

A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in Healthy Subjects

Alzheimer's Disease

United States
AdAlta Limited

Completed

Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney Disease

Chronic Kidney Diseases | Interstitial Lung Disease

Australia
AdAlta Limited

Completed

Phase 1 Safety, Tolerability, PK & PD Study of AD-214 Administered to Healthy Volunteers

Interstitial Lung Disease

Australia
Kyowa Kirin Co., Ltd.

Completed

A Comparative Study of KW-2246 (2246-004)

Cancer Related Pain (Breakthrough Pain)

Japan
Hunazine Biotech S.L.

Recruiting

Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera

Cholera

Bangladesh
Kang Stem Biotech Co., Ltd.

Completed

Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD)

Atopic Dermatitis

Korea, Republic of
PiLeJe

Completed

Exploratory Study on Lactibiane Topic AD on Skin Flora and Barrier Reinforcement in Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

France
Alzheimer's Disease Expert Lab (ADEL), Inc.
Oscotec Inc.

Recruiting

A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01

Alzheimer Disease

United States
Zhejiang Hisun Pharmaceutical Co. Ltd.
Medpace, Inc.

Unknown

Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease (ROAD)

Alzheimer Disease, Early Onset

United States
Samus Therapeutics, Inc.

Withdrawn

Evaluate PU-AD in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)
Genentech, Inc.

Completed

A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn's Disease (CD)

Crohn's Disease | Ulcerative Colitis

United Kingdom, Germany
Takeda

Completed

A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322

Diabetes Mellitus

Japan
Navy General Hospital, Beijing
Peking Union Medical College Hospital; Cancer Institute and Hospital, Chinese... and other collaborators

Unknown

Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia

Severe Aplastic Anemia

China
University of California, San Diego
Memgen, LLC

Completed

Pharmacodynamic (PD) Study of Intranodal Adenovirus-CD154 (Ad-ISF35) in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Hospices Civils de Lyon

Completed

Predictive Value of Biomarkers of the Alzheimer's Disease (AD) in Elderly Patients With New-onset Epilepsy (BIOMALEPSIE)

Epilepsy

France
Vaxart

Completed

Safety Study of an Oral Vaccine to Prevent Avian Influenza (H5N1)

Avian Influenza | Bird Flu

United States
Takeda

Terminated

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

Mild Cognitive Impairment Due to Alzheimer's Disease

United States, Australia, United Kingdom, Switzerland
University of Florida
Lallemand Bio-Ingredients

Completed

Fermented Soy and Heartburn Symptom Relief

Heartburn | Acid Regurgitation

United States
Takeda

Completed

Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants

Healthy

United States
Shenzhen Bay Laboratory
National Natural Science Foundation of China; Guangdong Basic and Applied Basic... and other collaborators

Recruiting

Greater-Bay-Area Healthy Aging Brain Study (GHABS) (GHABS)

Alzheimer's Disease

China
Translational Research Center for Medical Innovation...
Daiichi Sankyo Co., Ltd.

Completed

Exploratory Study for the Validity of QuQu Scale (QuQu)

Alzheimer Dementia

Japan
University of Michigan Rogel Cancer Center
Phase One Foundation

Completed

Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma

Glioblastoma Multiforme | Malignant Glioma

United States
Kang Stem Biotech Co., Ltd.

Recruiting

Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD) (smart(FURIN))

Dermatitis, Atopic

Korea, Republic of
Myles Wolf
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)

Kidney Disease

United States
Bristol-Myers Squibb

Completed

A Study to Evaluate the Safety, Tolerability, and Drug Levels of MYK-224 Administered in Single and Multiple Doses in Healthy Adult Japanese Participants

Healthy Volunteers

United States
Northwestern University

Completed

Acupressure in Pruritus for Atopic Dermatitis

Atopic Dermatitis

United States
Genentech, Inc.

Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)

Ulcerative Colitis

Italy, Spain, Serbia, Poland, Russian Federation, United States, Ukraine, Bulgaria, Georgia, Germany, Greece, Hungary, Ireland, Israel, Moldova, Republic of, United Kingdom
University Hospital, Montpellier

Recruiting

A Prospective Cohort Study of Patients Suffering From Hand Osteoarthritis Symptoms (COARDIG)

Hand Osteoarthritis

France
Crucell Holland BV
The PATH Malaria Vaccine Initiative (MVI); Seattle Children's Research Institute...

Completed

A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model

Malaria

United States
Bristol-Myers Squibb

Recruiting

Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) (AURORA-HFpEF)

Heart Failure

United States, Spain, Canada, Italy, Poland
Baylor College of Medicine
National Institute of Mental Health (NIMH)

Completed

Cognitive Behavior Therapy for Treating Anxiety in People With Dementia

Anxiety Disorders | Dementia

United States
University Hospital, Basel, Switzerland
Novartis; Swiss National Science Foundation

Completed

Canakinumab in Patients With COVID-19 and Type 2 Diabetes (CanCovDia)

Coronavirus Infection | Diabetes Mellitus, Type 2

Switzerland
Merck Sharp & Dohme LLC
HIV Vaccine Trials Network

Terminated

Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)

HIV Infections | AIDS
Integrative Health Technologies, Inc.

Unknown

Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular Health (AdBiotech)

Hyperlipidemia | Hypercholesteremia | Cholesterol

United States
Vaxart

Completed

Safety Study of an Oral Vaccine to Prevent Seasonal Influenza

Influenza

United States
Kansas City Heart Rhythm Research Foundation
Kansas City Heart and Rhythm Institute, Overland Park, KS; Bariatric and Metabolic...

Recruiting

Autonomic Dysfunction in Patients Following Bariatric Surgery: The ADiPOSE Study

Orthostatic Intolerance | Autonomic Dysfunction

United States
National Institute of Allergy and Infectious Diseases...
Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) and other collaborators

Completed

Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults (REPRIEVE)

Cardiovascular Diseases | HIV Infections

Brazil, Spain, United States, Puerto Rico, Haiti, Zimbabwe, Botswana, South Africa, Thailand, Uganda, India, Peru, Canada
Addpharma Inc.

Completed

A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole

Gastritis

Korea, Republic of
Addpharma Inc.

Completed

Evaluating the Pharmacokinetic Characteristics of AD-101 in Healthy Volunteers

Osteoporosis

Korea, Republic of
Takeda

Terminated

Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure

Diabetes Mellitus
Christopher Bell
AstraZeneca

Terminated

Does Dapagliflozin Promote Favorable Health Benefits That Are Independent Of Weight Loss?

Weight Loss

United States
Takeda

Completed

Safety Study of Pioglitazone Compared To Glyburide on Liver Function

Diabetes Mellitus | Liver

Search clinical trials for: Placebo of AD-224C

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations